Jan Malcolm is Director at UNITED THERAPEUTICS Corp (UTHR). They have made 1 open-market trade across 1 company since 2025, most recently 2026-07-10.
CIK 0002028640
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| UTHR | 450 | $240K |
Shares reported on the most recent Form 4, priced at the 2026-07-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UTHR | SELL · 10b5-1 | 2026-07-10 | 2026-07-10 | $550.59 | $179K | -2.3% | -1.8% | -1.2% |
| UTHR | SELL · 10b5-1 | 2026-03-17 | 2026-03-17 | $533.51 | $24K | -2.9% | +7.8% | +1.9% |
| UTHR | SELL · 10b5-1 | 2026-03-03 | 2026-03-03 | $509.20 | $25K | +7.9% | +13.7% | +9.7% |
| UTHR | SELL · 10b5-1 | 2026-02-17 | 2026-02-17 | $474.68 | $24K | +5.2% | +10.0% | +18.4% |
| UTHR | SELL · 10b5-1 | 2026-02-03 | 2026-02-03 | $474.23 | $24K | -1.7% | +0.6% | +20.6% |
| UTHR | SELL · 10b5-1 | 2026-01-16 | 2026-01-20 | $460.98 | $23K | +0.0% | +2.4% | +22.2% |
| UTHR | SELL · 10b5-1 | 2026-01-05 | 2026-01-06 | $495.01 | $25K | -7.7% | -4.9% | +11.1% |
| UTHR | SELL · 10b5-1 | 2025-12-23 | 2025-12-23 | $512.12 | $26K | -2.0% | -8.0% | +1.6% |
| UTHR | SELL · 10b5-1 | 2025-12-11 | 2025-12-12 | $482.98 | $24K | +4.7% | -1.9% | +8.3% |
| UTHR | SELL | 2025-09-09 | 2025-09-10 | $400.29 | $280K | +4.6% | +11.0% | +20.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.